Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Shota Fukuoka

Showing results (1-10 of 59) with videos related to

Pageof 6
Sort By:
Gan to Kagaku Ryoho. Cancer & Chemotherapy|January 19, 2015
[Efficacy of TAS-102]Daisuke Kotani, Shota Fukuoka, Takayuki Yoshino
Genes & Genetic Systems|February 21, 2024
RNA synthesis in liposomes with negatively charged lipids after fusion via freezing-thawingGakushi Tsuji, Ayu Shimomura, Shota Fukuoka, et al.
Journal of Biochemistry|June 13, 2025
Transcription and translation efficiency is reduced in cholesterol-containing liposomesShota Fukuoka, Ayu Shimomura, Yuya Katsumura, et al.
Oncology|December 8, 2024
Comparing the Efficacy of a Triplet Antiemetic Regimen in Patients with Esophageal Cancer and Diabetes Mellitus Treated with Cisplatin-Based Chemotherapy: A Retrospective StudyMasahiro Hatori, Shota Fukuoka, Shunya Kimura, et al.
Oncology|July 29, 2025
Impact of comorbidity on antiemetic efficacy in patients with esophageal cancer treated with cisplatin-based chemotherapy: A retrospective study from JapanMasahiro Hatori, Shota Fukuoka, Shunya Kimura, et al.
Gan to Kagaku Ryoho. Cancer & Chemotherapy|September 20, 2013
[A case of blastic plasmacytoid dendritic cell neoplasm involving the skin]Shota Fukuoka, Yoshitaka Miyakawa, Takahiro Suzuki, et al.
The Oncologist|May 8, 2026
Predictive factors for early mortality after regorafenib or trifluridine/tipiracil initiation in metastatic colorectal cancerToshiki Masuishi, Shota Fukuoka, Atsuo Takashima, et al.
The Oncologist|April 17, 2026
Predictive factors for early mortality after regorafenib or trifluridine/tipiracil initiation in metastatic colorectal cancerToshiki Masuishi, Shota Fukuoka, Atsuo Takashima, et al.
International Journal of Systematic and Evolutionary Microbiology|November 2, 2021
<i>Vescimonas</i> gen. nov., <i>Vescimonas coprocola</i> sp. nov., <i>Vescimonas fastidiosa</i> sp. nov., <i>Pusillimonas</i> gen. nov. and <i>Pusillimonas faecalis</i> sp. nov. isolated from human faecesMaki Kitahara, Yuko Shigeno, Mari Shime, et al.
Gastric Cancer : Official Journal of the International Gastric Cancer Association and the Japanese Gastric Cancer Association|November 7, 2024
Advantages of adjuvant chemotherapy using S-1 following minimally invasive gastrectomy for gastric cancer versus open surgery: a propensity score-matched analysisMotonari Ri, Naoki Nishie, Manabu Ohashi, et al.
Pageof 6

Showing results (1-10 of 59) with videos related to

Sort By:
Pageof 6
Gan to Kagaku Ryoho. Cancer & Chemotherapy|January 19, 2015
[Efficacy of TAS-102]Daisuke Kotani, Shota Fukuoka, Takayuki Yoshino
Genes & Genetic Systems|February 21, 2024
RNA synthesis in liposomes with negatively charged lipids after fusion via freezing-thawingGakushi Tsuji, Ayu Shimomura, Shota Fukuoka, et al.
Journal of Biochemistry|June 13, 2025
Transcription and translation efficiency is reduced in cholesterol-containing liposomesShota Fukuoka, Ayu Shimomura, Yuya Katsumura, et al.
Oncology|December 8, 2024
Comparing the Efficacy of a Triplet Antiemetic Regimen in Patients with Esophageal Cancer and Diabetes Mellitus Treated with Cisplatin-Based Chemotherapy: A Retrospective StudyMasahiro Hatori, Shota Fukuoka, Shunya Kimura, et al.
Oncology|July 29, 2025
Impact of comorbidity on antiemetic efficacy in patients with esophageal cancer treated with cisplatin-based chemotherapy: A retrospective study from JapanMasahiro Hatori, Shota Fukuoka, Shunya Kimura, et al.
Gan to Kagaku Ryoho. Cancer & Chemotherapy|September 20, 2013
[A case of blastic plasmacytoid dendritic cell neoplasm involving the skin]Shota Fukuoka, Yoshitaka Miyakawa, Takahiro Suzuki, et al.
The Oncologist|May 8, 2026
Predictive factors for early mortality after regorafenib or trifluridine/tipiracil initiation in metastatic colorectal cancerToshiki Masuishi, Shota Fukuoka, Atsuo Takashima, et al.
The Oncologist|April 17, 2026
Predictive factors for early mortality after regorafenib or trifluridine/tipiracil initiation in metastatic colorectal cancerToshiki Masuishi, Shota Fukuoka, Atsuo Takashima, et al.
International Journal of Systematic and Evolutionary Microbiology|November 2, 2021
<i>Vescimonas</i> gen. nov., <i>Vescimonas coprocola</i> sp. nov., <i>Vescimonas fastidiosa</i> sp. nov., <i>Pusillimonas</i> gen. nov. and <i>Pusillimonas faecalis</i> sp. nov. isolated from human faecesMaki Kitahara, Yuko Shigeno, Mari Shime, et al.
Gastric Cancer : Official Journal of the International Gastric Cancer Association and the Japanese Gastric Cancer Association|November 7, 2024
Advantages of adjuvant chemotherapy using S-1 following minimally invasive gastrectomy for gastric cancer versus open surgery: a propensity score-matched analysisMotonari Ri, Naoki Nishie, Manabu Ohashi, et al.
Pageof 6